BioCurex Announces Commercialization Of OncoPet RECAFTM, The First Blood Test For Cancer Detection In Companion Animals
BioCurex Inc. (OTCBB:BOCX), a biotechnology company developing products based on patented technology in the areas of cancer diagnostics, announced that it has launched the commercialization of its OncoPet RECAF test for cancer detection in dogs. The test detected 85 percent of a variety of cancers in dogs, at the standard 95 percent specificity level in pre-market studies. The Company believes that this launch represents the first commercialization of a blood-based test for the universal detection of cancer in companion animals...

Source: feedproxy.google.com

Keeping Tumor Growth Switched Off: New Drug Created By Researchers
A novel - and rapid - anti-cancer drug development strategy has resulted in a new drug that stops kidney and pancreatic tumors from growing in mice. Researchers at the Moores Cancer Center at the University of California, San Diego, have found a drug that binds to a molecular "switch" found in cancer cells and cancer-associated blood vessels to keep it in the "off" position...

Source: feedproxy.google.com

Medical Radiation Exposure Safeguards Should Be Tighter Says FDA
The US Food and Drug Administration (FDA) says safeguards for avoiding unnecessary exposure to medical radiation should be tightened and announced a new three-pronged initiative on Tuesday to increase oversight of the biggest contributors: computed tomography (CT), nuclear medicine studies, and fluoroscopy...
Source: mnt.to

Researchers Find Air Pollution Linked To Progression Of Atherosclerosis
Researchers at the Keck School of Medicine of the University of Southern California (USC), in collaboration with international partners in Spain and Switzerland and colleagues in California, have found that exposure to air pollution accelerates the thickening of artery walls that leads to cardiovascular disease. The study, published this week in the journal PloS ONE, is the first to link outdoor air quality and progression of atherosclerosis in humans...

Source: feedproxy.google.com

Rye More Filling Than Wheat
Wholegrain bread is good and good for you, as most people know. But it is not only the fiber-rich bran, the outer shell of the grain, that is healthful. On the contrary, research at the Lund University Faculty of Engineering shows that bread baked with white rye flour, which is flour made from the inner, white part of the rye kernel, leads to better insulin and blood sugar levels compared with wheat bread with rye bran. White rye flour thus leads to much better values than both regular wheat flour and rye bran...

Source: feedproxy.google.com

The Genetic Secrets To Jumping The Species Barrier
Scientists have pinpointed specific mutations that allow a common plant virus to infect new species, according to research published in the March issue of the Journal of General Virology. Understanding the genetics of the key interactions between viruses and hosts could provide insight to how some viruses manage to jump the species barrier and even give us a better idea of how animal diseases are generated...

Source: feedproxy.google.com

Can Chocolate Lower Your Risk Of Stroke?
Eating chocolate may lower your risk of having a stroke, according to an analysis of available research that will be released and presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010. Another study found that eating chocolate may lower the risk of death after suffering a stroke...
Source: mnt.to

Obesity And Diabetes Study Weighs Influence Of Genetics, Lifestyle
A team of Northern Arizona University-led researchers is using nearly $1.3 million in new funding from the National Institutes of Health to continue with the world's longest-running study on obesity and Type 2 diabetes. Obesity and diabetes have been described as the major public health concerns of the 21st century, explains Leslie Schulz, executive dean of NAU's College of Health and Human Services and the study's principal investigator. "This study is taking those necessary steps toward finding a way to protect people against the development of these pervasive diseases," she says...

Source: feedproxy.google.com

Taking Medicine For HIV Proves Hard To Swallow For Many People
Highly active antiretroviral therapy has increased the longevity and quality of life for people living with human immunodeficiency virus. But it requires strict adherence in taking the medicine, something that is extremely difficult for many individuals to do. Two new University of Washington studies illustrate just how hard it is to make sure people take their HIV medication...
Source: mnt.to

Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow two earlier successful phase II studies with the company's T-cell vaccine against cat allergy...

Source: feedproxy.google.com